NAVLE Multisystemic

Equine Anhidrosis Study Guide

📅 March 28, 2026 ⏱ 25 min read

Overview and Clinical Importance

Anhidrosis (also known as dry coat syndrome or non-sweating disease) is a thermoregulatory disorder characterized by the decreased or complete inability to sweat in response to appropriate stimuli such as exercise or elevated ambient temperature. This condition primarily affects horses living in hot, humid climates and represents a significant performance-limiting and potentially life-threatening condition in equine practice.

Horses rely on sweating as their primary mechanism for thermoregulation, with 65-70% of excess body heat dissipated through sweat evaporation. The equine skin contains approximately 810 sweat glands per square centimeter, making horses exceptional sweaters among domestic animals. When this cooling mechanism fails, affected horses are at severe risk of hyperthermia, heat stroke, and death.

High-YieldAnhidrosis is most prevalent in hot, humid climates such as Florida, the Gulf Coast states, and tropical regions. Prevalence ranges from 2-6% of horses overall, but can affect up to 20-25% of athletic Thoroughbreds in endemic areas.

Component	Concentration	Clinical Significance
Sodium	Higher than plasma	Hypertonic sweat unique to horses
Potassium	Significantly higher than plasma	Major electrolyte loss during sweating
Chloride	Higher than plasma	Reduced urinary excretion in anhidrosis
Proteins	Glycoproteins, surfactants	Creates characteristic lather

Etiology and Pathophysiology

Normal Equine Sweat Physiology

Equine sweat glands are primarily of the apocrine type, associated with hair follicles throughout the body. Sweating is controlled by both neural and humoral mechanisms through beta-2 adrenergic receptors on sweat gland secretory cells. Circulating epinephrine released during exercise and stress, along with direct neural release of norepinephrine from adrenergic nerve endings, stimulates these receptors to initiate sweat production.

Equine Sweat Composition

Proposed Pathophysiologic Mechanisms

The exact cause of anhidrosis remains incompletely understood, but current evidence supports beta-2 adrenergic receptor downregulation and desensitization as the primary mechanism. Prolonged exposure to hot, humid conditions results in chronic overstimulation of sweat gland receptors by circulating catecholamines, leading to receptor exhaustion.

NAVLE TipRemember the progression: Acute anhidrosis shows functional receptor dysfunction with normal gland structure. Chronic anhidrosis shows irreversible glandular atrophy. This explains why early intervention and climate change can restore sweating in acute cases but not chronic ones.

Proposed Mechanism	Description and Evidence
Beta-2 Receptor Downregulation	Chronic catecholamine overstimulation leads to receptor internalization and decreased surface expression. Beta-adrenergic agonists fail to stimulate sweating in affected horses.
Chloride Channel Dysfunction	Macrolide antibiotics cause temporary anhidrosis in foals by affecting chloride transport. Suggests ion channel involvement in sweat production.
Sweat Gland Atrophy	Chronic cases show ultrastructural changes: thickened basal lamina, reduced secretory vesicles, ductal obstruction with cellular debris. Changes may be irreversible.
Aquaporin-5 Reduction	Decreased expression of water channel proteins in severely anhidrotic horses suggests impaired water transport into sweat gland lumen.
Genetic Predisposition	KCNE4 gene (potassium channel subunit) associated with chronic anhidrosis. Horses with family history are 22 times more likely to develop condition.

Epidemiology and Risk Factors

High-YieldThe condition was first recognized in British Thoroughbreds imported to tropical colonies in the 1920s. Being born and raised in a hot climate is NOT protective - both locally-bred and imported horses develop anhidrosis at similar rates.

Factor	Details
Overall Prevalence	2-6% of horses in endemic areas; up to 20-25% of athletic Thoroughbreds in Florida
Geographic Distribution	Florida, Gulf Coast states, tropical/subtropical regions worldwide; odds 4.4 times higher in southern vs northern Florida
Breed Predisposition	Thoroughbreds and Warmbloods at highest risk; all breeds can be affected
Age/Sex/Color	No definitive association; some anecdotal reports of dark-colored horses being more affected
Activity Level	Show horses and riding instruction operations at 5-15 times higher risk than ranch operations
Family History	Odds 21.7 times higher with affected family members - strong genetic component
Origin	Horses from western/midwestern US relocated to hot climates at increased risk

Clinical Signs and Presentation

Acute Presentation

Onset may be sudden or gradual. Initial signs often precede complete loss of sweating:

Excessive sweating phase: Many horses experience a period of profuse sweating before transitioning to anhidrosis
Partial sweating: Initially may sweat only under mane, in saddle area, or inguinal/perineal regions
Exercise intolerance: Often the first owner-noticed sign; decreased performance during work
Tachypnea: Respiratory rate 60-120+ breaths/minute with nostril flaring; persists more than 30 minutes post-exercise
Hyperthermia: Rectal temperature up to 104-106 degrees F (normal: 99.5-100.5 degrees F); prolonged recovery time

Chronic Presentation

Dry, flaky skin: Especially prominent on the forehead; characteristic finding
Alopecia: Focal or generalized hair loss; thinning, dull coat quality
Anorexia: Decreased appetite from chronic heat stress
Decreased water consumption: Paradoxically reduced despite heat stress
Lethargy/depression: Decreased activity level; heat-seeking behavior (seeking shade, standing in water)

Clinical Signs by Severity

Exam Focus: The term 'puff disease' or 'blowers' refers to the characteristic persistent tachypnea as affected horses attempt compensatory respiratory heat loss. This is an adaptive mechanism similar to panting in dogs.

Severity	Sweating Pattern	Associated Signs
Mild	Reduced sweating; damp under tack only	Subtle performance decline; slightly prolonged recovery
Moderate	Patchy sweating; mane, inguinal areas only	Obvious exercise intolerance; tachypnea more than 60/min; skin changes
Severe	Complete absence of sweating	Life-threatening hyperthermia; collapse risk; alopecia; anorexia

Diagnosis

Clinical Assessment

Diagnosis is often presumptive based on compatible history (hot/humid climate, exercise intolerance, failure to sweat) and clinical examination. Key findings include:

Dry coat in situations that should elicit copious sweating
Elevated respiratory rate more than 30 minutes post-exercise
Prolonged elevation of rectal temperature post-exercise
Characteristic skin changes (dry, flaky skin especially on forehead)

Intradermal Sweat Testing

Confirmatory testing utilizes intradermal injections of terbutaline (preferred - selective beta-2 agonist) or epinephrine (alpha and beta agonist) to stimulate local sweat production.

Intradermal Sweat Test Protocol

Additional Diagnostics

Serum electrolytes: Evaluate for imbalances; decreased urinary fractional excretion of chloride is a consistent finding
Thyroid panel: Rule out hypothyroidism (not consistently associated but often tested)
ACTH/Cortisol: Screen for PPID (Cushing's disease) as anhidrosis can be associated
Skin biopsy: Rarely needed; may show sweat gland atrophy in chronic cases

Differential Diagnosis

Primary respiratory disease (heaves, RAO)
Cardiac disease
Heat stroke/exhaustion
PPID (Pituitary Pars Intermedia Dysfunction)
Drug-induced anhidrosis (macrolide antibiotics, antihistamines)

Step	Procedure
Preparation	Clip hair over lateral neck; prepare serial dilutions of terbutaline (1:1000 to 1:1,000,000) or epinephrine
Injection	Inject 0.1 mL of each dilution intradermally using 25-gauge needle; space injections 5-10 cm apart; include saline control
Assessment	Evaluate sweat response at 30 minutes; can use absorbent pads for quantitative measurement
Normal Response	Sweating evident at all injection sites within 15-30 minutes
Partial Anhidrosis	Sweating only at highest concentration sites (1:1000); delayed response
Complete Anhidrosis	No sweating at any concentration; may take more than 5 hours for minimal response at highest dose

Treatment and Management

There is no proven cure for anhidrosis. The only consistently effective intervention is relocating the horse to a cooler climate. Management focuses on preventing hyperthermia and supporting quality of life while hoping for spontaneous recovery.

Management Strategies

Emergency Management of Hyperthermia

If an anhidrotic horse develops severe hyperthermia (more than 104 degrees F), immediate cooling is critical:

Move to shade immediately; provide airflow with fans
Apply cool water continuously (do NOT use ice water - causes peripheral vasoconstriction)
Apply isopropyl alcohol to enhance evaporative cooling
IV fluids for severe cases
Monitor rectal temperature every 5-10 minutes until below 102 degrees F

NAVLE TipBeta-2 agonists like clenbuterol are NOT effective treatments because the condition is caused by downregulation of these very receptors. Using beta agonists may actually worsen receptor desensitization. Thyroid supplementation (levothyroxine) has anecdotal success, possibly by enhancing beta receptor sensitivity.

Strategy	Implementation
Climate Relocation	Moving to cooler climate is most effective; horses often resume sweating within 10-30 days in temperate environment
Environmental Modification	Air-conditioned stalls; fans for constant airflow; shade access; water misters; nighttime turnout
Exercise Modification	Exercise only during cooler morning/evening hours; reduce intensity; extended cool-down periods with water hosing
Electrolyte Supplementation	Daily sodium, chloride, potassium; 'Lite salt' (potassium chloride) supplementation; ensures adequate hydration
Nutritional Supplements	One AC (L-tyrosine, B vitamins, niacin); Vitamin E; anecdotal benefit - no proven efficacy
Acupuncture	TCVM approach targeting 'Summer Heat' pattern; points BL-13, KID-7, SP-6; modest evidence in recent cases; requires ongoing treatment
Dark Beer (Anecdotal)	Guinness or other dark stout; popular folklore remedy; no scientific evidence; may provide B vitamins

Prognosis

Prognosis depends on severity, chronicity, and management options:

Acute cases: Good prognosis with climate relocation; many horses resume normal sweating
Chronic cases: Guarded; irreversible sweat gland atrophy may prevent recovery
Managed in hot climate: Can maintain quality of life with strict management; athletic career often limited
Seasonal pattern: Some horses show improvement with cooler weather; may recur each summer

Memory Aids

"DRY COAT" Mnemonic for Clinical Signs

D - Dry, flaky skin (especially forehead)

R - Respiratory rate elevated (tachypnea/panting)

Y - "Yikes! No sweat!" in appropriate conditions

C - Climate hot/humid

O - Overheating (hyperthermia)

A - Alopecia (hair loss)

T - Temperature won't come down

"SWEAT TEST" Mnemonic for Diagnosis

S - Serial dilutions prepared

W - Wipe and clip neck area

E - Epinephrine or terbutaline injection

A - Assess at 30 minutes

T - Terbutaline preferred (specific beta-2)

High-YieldRemember '22 Times' - horses with a family history are 22 times more likely to develop anhidrosis, strongly supporting the genetic component. Also remember '65-70%' - the percentage of heat loss that occurs via sweating in horses, explaining why anhidrosis is so debilitating.

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →